𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant interleukin-2 and recombinant interferon α immunotherapy cardiovascular toxicity

✍ Scribed by D. Schechter; A. Nagler

Book ID
115659831
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
429 KB
Volume
123
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy of advanced renal cell can
Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α
✍ H. Kirchner; W. Riese; E. Allhoff; H. Poliwoda; J. Atzpodien 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

The combined administration of subcutaneous recombinant human interleukin-2 (rIL-2) and interferon-a (rIFN-~) was studied in a phase II trial on patients with advanced progressive renal cell cancer. Safety, tolerance and clinical response rate of this outpatient treatment protocol were assessed in 2

Combination tumor-immunotherapy with rec
Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice
✍ Takashi Nishimura; So Ohta; Naoko Sato; Yuji Togashi; Makiko Goto; Yoshiyuki Has 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 656 KB

Recombinant human tumor necrosis factor (r-TNF) inhibits growth of various mouse tumor cell lines both in vitro and in vivo. Treatment of established tumor nodules with intratumoral (i.t.) injection of r-TNF caused hemorrhagic necrosis of tumor and temporary disappearance of tumor mass. However, a s

Eradication of mouse melanoma by combine
Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma
✍ Selma Silagi; Regina Dutkowski; Annette Schaefer 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 904 KB

Successful immunotherapy of early S.C. or i.p. (816) melanoma in syngeneic C57BL/6 (86) mice was achieved with S.C. peri-lesional injections (for S.C. tumors) o r i.p. injections (for i.p. tumors) of recombinant human interleukin 2 (rlL-2) and recombinant murine interferon-gamma (rlFN-7). Over a 28d